ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan
· Delayed Price · Currency is TWD 19.05
-0.15 (-0.78%)
May 9, 2025, 1:35 PM CST
ScinoPharm Taiwan Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 8, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 15,064 | 17,436 | 20,876 | 20,124 | 19,492 | 22,813 | Upgrade
|
| Market Cap Growth | -24.05% | -16.48% | 3.73% | 3.25% | -14.56% | 8.46% | Upgrade
|
| Enterprise Value | 12,663 | 14,136 | 17,530 | 16,527 | 16,275 | 19,607 | Upgrade
|
| Last Close Price | 19.05 | 22.05 | 26.13 | 24.88 | 23.64 | 27.11 | Upgrade
|
| PE Ratio | 61.19 | 51.38 | 72.72 | 56.98 | 80.06 | 80.88 | Upgrade
|
| Forward PE | - | 108.27 | 102.52 | 52.60 | 115.41 | 115.41 | Upgrade
|
| PS Ratio | 4.69 | 5.12 | 6.55 | 6.17 | 7.06 | 7.40 | Upgrade
|
| PB Ratio | 1.41 | 1.66 | 2.01 | 1.93 | 1.85 | 2.17 | Upgrade
|
| P/TBV Ratio | 1.41 | 1.66 | 2.02 | 1.93 | 1.86 | 2.17 | Upgrade
|
| P/FCF Ratio | 60.62 | 37.04 | - | 37.93 | 99.76 | 29.77 | Upgrade
|
| P/OCF Ratio | 27.73 | 23.22 | 90.32 | 26.01 | 38.23 | 24.11 | Upgrade
|
| EV/Sales Ratio | 3.95 | 4.15 | 5.50 | 5.06 | 5.89 | 6.36 | Upgrade
|
| EV/EBITDA Ratio | 17.95 | 17.85 | 23.07 | 19.93 | 24.83 | 25.99 | Upgrade
|
| EV/EBIT Ratio | 60.46 | 44.03 | 55.74 | 40.76 | 56.39 | 52.18 | Upgrade
|
| EV/FCF Ratio | 50.96 | 30.03 | - | 31.15 | 83.29 | 25.59 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.06 | 0.06 | 0.07 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.99 | 0.83 | 0.80 | 0.80 | 0.83 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 2.80 | 1.44 | - | 1.28 | 2.85 | 0.75 | Upgrade
|
| Asset Turnover | 0.27 | 0.29 | 0.27 | 0.28 | 0.24 | 0.26 | Upgrade
|
| Inventory Turnover | 1.18 | 1.32 | 1.46 | 1.59 | 1.14 | 1.49 | Upgrade
|
| Quick Ratio | 4.86 | 6.24 | 6.52 | 6.16 | 8.04 | 6.59 | Upgrade
|
| Current Ratio | 7.53 | 8.61 | 8.75 | 7.87 | 10.73 | 8.62 | Upgrade
|
| Return on Equity (ROE) | 2.31% | 3.25% | 2.76% | 3.37% | 2.31% | 2.71% | Upgrade
|
| Return on Assets (ROA) | 1.09% | 1.70% | 1.66% | 2.15% | 1.53% | 2.00% | Upgrade
|
| Return on Capital (ROIC) | 1.16% | 1.81% | 1.78% | 2.28% | 1.63% | 2.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.80% | 2.90% | 2.90% | 3.70% | 2.60% | 3.40% | Upgrade
|
| Earnings Yield | 1.63% | 1.95% | 1.38% | 1.75% | 1.25% | 1.24% | Upgrade
|
| FCF Yield | 1.65% | 2.70% | -0.18% | 2.64% | 1.00% | 3.36% | Upgrade
|
| Dividend Yield | 1.84% | 1.59% | 1.15% | 1.45% | 2.03% | 1.84% | Upgrade
|
| Payout Ratio | 96.69% | 69.91% | 99.17% | 107.46% | 162.39% | 75.69% | Upgrade
|
| Buyback Yield / Dilution | 0.26% | -0.07% | 0.04% | -0.05% | -0.01% | -0.01% | Upgrade
|
| Total Shareholder Return | 2.10% | 1.52% | 1.19% | 1.40% | 2.02% | 1.83% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.